RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      분무건조기를 이용한 아토르바스타틴 고체분산체의 용출율 개선 = Improved Dissolution of Solid Dispersed Atorvastatin Using Spray-Dryer

      한글로보기

      https://www.riss.kr/link?id=A104997993

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Solid dispersions of poorly water-soluble drug, atorvastatin, were prepared with Eudragit L100 to improve the solubility by spray dryer. To investigate the correlation between physicochemical properties and dissolution rate of solid
      dispersions, the samples were characterized by scanning electron microscopy (SEM), differential scanning calorimeter (DSC) and fourier transform infrared spectroscopy (FT-IR). SEM and DSC were found that atorvastatin is amorphous in the Eudragit L100 solid dispersion. FT-IR was used to analyze the salt formation by interaction between atorvastatin and
      Eudragit L100. The dissolution rate of solid dispersed atorvastatin was markedly increased compared to drug powder in stimulated intestinal juice (pH 6.8). Thus, the solid dispersed atorvastatin using the spray drying method with Eudragit L100 may be effective for the bioavailability.
      번역하기

      Solid dispersions of poorly water-soluble drug, atorvastatin, were prepared with Eudragit L100 to improve the solubility by spray dryer. To investigate the correlation between physicochemical properties and dissolution rate of solid dispersions, the s...

      Solid dispersions of poorly water-soluble drug, atorvastatin, were prepared with Eudragit L100 to improve the solubility by spray dryer. To investigate the correlation between physicochemical properties and dissolution rate of solid
      dispersions, the samples were characterized by scanning electron microscopy (SEM), differential scanning calorimeter (DSC) and fourier transform infrared spectroscopy (FT-IR). SEM and DSC were found that atorvastatin is amorphous in the Eudragit L100 solid dispersion. FT-IR was used to analyze the salt formation by interaction between atorvastatin and
      Eudragit L100. The dissolution rate of solid dispersed atorvastatin was markedly increased compared to drug powder in stimulated intestinal juice (pH 6.8). Thus, the solid dispersed atorvastatin using the spray drying method with Eudragit L100 may be effective for the bioavailability.

      더보기

      참고문헌 (Reference)

      1 강길선, "자가미세유화를 통한 아토르바스타틴 칼슘의 난용성 개선" 한국약제학회 37 (37): 339-347, 2007

      2 김경환, "이우주의 약리학개론" 의학문화사 473-475, 1998

      3 강길선, "아토르바스타틴 칼슘 고체분산체의 특성화 및 용출율 개선" 한국약제학회 38 (38): 111-117, 2008

      4 강길선, "시부트라민 고체 분산체의 특성화 및 조절된 방출거동" 한��약제학회 38 (38): 119-126, 2008

      5 박정수, "분무건조 방법으로 제조된 미립구에서 Sibutramine의 방출거동" 한국고분자학회 32 (32): 193-198, 2008

      6 M. Asada, "Theophylline particle design using chitosan by the spray drying" 270 : 167-174, 2004

      7 Röhm GmbH, "Specifications and test methods for EUDRAGITR L100 and EUDRAGITR S100" 2004

      8 J.N. Gyabaah, "Solubility of lovastatin in a family of six alcohols: Ethanol, 1-propanol, 1-butanol, 1-pentanol, 1-hexanol, and 1-octanol" 359 (359): 111-117, 2008

      9 M.S. Kim, "Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent(SAS) process" 69 (69): 454-465, 2008

      10 T. Ozeki, "Preparation of two-drug composite microparticles to improve the dissolution of insoluble drug in water for use with a 4-fluid nozzle spray drier" 107 : 387-394, 2005

      1 강길선, "자가미세유화를 통한 아토르바스타틴 칼슘의 난용성 개선" 한국약제학회 37 (37): 339-347, 2007

      2 김경환, "이우주의 약리학개론" 의학문화사 473-475, 1998

      3 강길선, "아토르바스타틴 칼슘 고체분산체의 특성화 및 용출율 개선" 한국약제학회 38 (38): 111-117, 2008

      4 강길선, "시부트라민 고체 분산체의 특성화 및 조절된 방출거동" 한��약제학회 38 (38): 119-126, 2008

      5 박정수, "분무건조 방법으로 제조된 미립구에서 Sibutramine의 방출거동" 한국고분자학회 32 (32): 193-198, 2008

      6 M. Asada, "Theophylline particle design using chitosan by the spray drying" 270 : 167-174, 2004

      7 Röhm GmbH, "Specifications and test methods for EUDRAGITR L100 and EUDRAGITR S100" 2004

      8 J.N. Gyabaah, "Solubility of lovastatin in a family of six alcohols: Ethanol, 1-propanol, 1-butanol, 1-pentanol, 1-hexanol, and 1-octanol" 359 (359): 111-117, 2008

      9 M.S. Kim, "Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent(SAS) process" 69 (69): 454-465, 2008

      10 T. Ozeki, "Preparation of two-drug composite microparticles to improve the dissolution of insoluble drug in water for use with a 4-fluid nozzle spray drier" 107 : 387-394, 2005

      11 B.K. Kang, "Preparation of solid dosage form containing SMEDDS of simvastatin by microencapsulation" 33 (33): 121-127, 2003

      12 H.R. Shen, "Preparation and evaluation of self-microemulsifying drug delivery systems(SMEDDS) contain- ing atorvastatin" 58 : 1183-1191, 2006

      13 G. Khang, "Preparation and characterization of PLGA microspheres for the sustained release of AZT" 8 (8): 80-88, 2000

      14 M.S. Kim, "Patent WO2003068191"

      15 T. Mizoe, "One-step preparation of drug-containing microparticles to enhance the dissolution and absorption of poorly water-soluble drugs using a 4-fluid nozzle spray drier" 120 : 205-210, 2007

      16 T.S. Chung, "Novel hollow fiber membranes with defined unit-step morphological change" 193 (193): 123-128, 2001

      17 D.D. Cilla, "Multiple-dose pharmacokinetics, pharmacodynamic and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects" 60 : 687-695, 1996

      18 L.S. Porubcan, "Mechanism of adsorption of clindamycin and tetracycline by montmorillonite" 67 : 1081-, 1978

      19 S.J. Lee, "Korea Patent, 10-2007-0094386"

      20 Röhm Pharma, "Information sheet, “Eudragit L” (1998)"

      21 K. Uekama, "Inclusion complexations of steroid hormones with cyclodextrins in water and in the solid-phase" 10 : 1-15, 1982

      22 B.Y. Yoon, "Improvement of bioavailability for lovastatin using selfemulsifying drug delivery system" 32 (32): 267-274, 2002

      23 D. Skorda, "Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy" 74 : 1066-1070, 2008

      24 M. Otsuka, "Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with Eudragit" 82 : 32-38, 1993

      25 H.B. Lee, "Fentanyl-loaded PLGA microspheres for local anesthesia" 40 (40): 288-289, 1999

      26 D.H. Choi, "Drug interaction between oral atorvastatin and verapamil in healthy subjects:Effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil" 64 : 445-449, 2008

      27 B.K. Kang, "Development of selfmicroemulsifying drug delivery system(SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs" 274 : 65-73, 2004

      28 P.D. Martino, "Characterization and compaction behaviour of nimesulide crystal forms" 342 : 137-144, 2007

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-06-09 학술지명변경 한글명 : 약제학회지 -> Journal of Pharmaceutical Investigation
      외국어명 : Jorunal of Korean Pharmaceutical Sciences -> Journal of Pharmaceutical Investigation
      KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-06-16 학회명변경 영문명 : The Korean Society Of Pharmaceutics -> The Korean Society of Pharmaceutical Sciences and Technology KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-07-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.18 0.18 0.14
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.13 0.11 0.374 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼